Diabetic complications may result from chronic glycosylation of protein within cells and in the extracellular matrix. Prevention of glycosylation with aminoguanidine has forestalled complications in experimental diabetes.
|Original language||English (US)|
|Number of pages||5|
|Issue number||SUPPL. 1|
|State||Published - Dec 1 1992|
ASJC Scopus subject areas